NCT03503747View on ClinicalTrials.gov

Investigating Genetic Risk for Type 1 Diabetes

CompletedOBSERVATIONAL

Enrollment

15,640

Participants

Timeline

Start Date

April 25, 2018

Primary Completion Date

August 31, 2021

Study Completion Date

August 31, 2021

Conditions

Diabetes Mellitus, Type 1Diabetes MellitusGlucose Metabolism DisordersMetabolic DiseaseEndocrine System DiseasesAutoimmune DiseasesImmune System Diseases

Trial Locations (1)

Unknown

Oxford University Hospitals NHS Trust, Oxford

All Listed Sponsors

lead

University of Oxford

OTHER

NCT03503747 - Investigating Genetic Risk for Type 1 Diabetes | Biotech Hunter | Biotech Hunter